In this day and age, pharmaceutical consulting firms provide a strategic service for companies involved in this dynamic industry and provide a crucial extra element as the company battles through uncertain times. Generally, pharmaceutical consultants are industry experts and have often assumed key roles in other areas within the healthcare industry before joining the consulting organisation. Their knowledge and recommendations do not come from textbooks, but from passion, ability and a wide range of personal experiences.

Now more than ever, it’s important for the pharmaceutical company to make the right, strategic decisions as they develop new products and continue to market existing products into the field. The journey between product manufacture and the patient involves numerous layers of bureaucracy, regulatory restrictions and enforcement, even though the patient is much in need of a product. It is in such a taught environment that the pharmaceutical consultant can be worth his or her weight in gold.

After many decades of consultation, it looks like legislation will soon change how the US healthcare industry looks and affect one of the world’s most complex industries. Nobody is sure just how these changes will affect organisations directly involved in the business and this change is likely to unfold over a period of many months and years. As everyone concerned must engage these changes and learn afresh, the prepared organisation will surely be able to capitalise on these opportunities in the years ahead. Change brings threats, but also opportunities and a forward thinking company will employ pharma consulting firms to make the most of these advantages and opportunities.

The selection of the pharmaceutical and healthcare consulting firm must be made on the basis of an organisation’s track record and its ability to operate on the leading edge. The consulting company must balance this experience with its ability to make judgements from a knowledgeable perspective and help to recommend that the organisation take certain steps to address specific challenges. Pharmaceutical consultants should be close at hand at all times as decision makers within the organisation will require their expert input and advice on a regular basis.

If key management decisions appear to be built on shaky ground, the pharmaceutical consultant should always be available and ready to implement a challenge to these positions, if better tactics and an alternate approach could result in a more profitable outcome. This is not to say that the consultant should take the upper hand, but it’s important that the consulting firm retains a somewhat unbiased or even a “devil’s advocate” position, drawing on experience and knowledge of other situations to provide valuable intelligence.

A pharma consulting firm should be able to anticipate trends by looking into its crystal ball and making sure that the organisation is advised of any potential threats or emerging issues that it should be aware of, if likely to impact a position. Sometimes market developments could serve to affect the development of a product that is under consideration and these developments may not be intuitive, so early intervention could in such circumstances make the difference between success or failure. We can see that a relationship between senior executives of the company and the pharmaceutical consulting firm should be very close, with proven synergy and results.

Alan Gillies is the CEO of L2L Consulting, a cutting-edge pharma consultancy firm which specialises in optimising productivity and performance within international companies by applying tailored organisational strategies.